# EDGAR Filing Document

**Accession Number:** 0001209466
**File Stem:** 0001209466-26-000892
**Filing Date:** 2026-6
**Character Count:** 24960
**Document Hash:** 3b7c51cc1188ae2561e233899977edba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209466-26-000892.hdr.sgml**: 20260626

**ACCESSION NUMBER**: 0001209466-26-000892

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260626

**DATE AS OF CHANGE**: 20260626

**PERIOD START**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVESCO EXCHANGE-TRADED FUND TRUST
- **CENTRAL INDEX KEY:** 0001209466

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21265
- **FILM NUMBER:** 261126850

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POWERSHARES EXCHANGE TRADED FUND TRUST
- **DATE OF NAME CHANGE:** 20021210

## Series and Classes Contracts Data

### Invesco Dorsey Wright Healthcare Momentum ETF (Series ID: S000013104)

| Class ID   | Class Name                                    | Ticker Symbol   |
|:---|:---|:---|
| C000035320 | Invesco Dorsey Wright Healthcare Momentum ETF | PTH             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-21265

- **c. CIK number of Registrant:** 0001209466

- **d. LEI of Registrant:** QPT4TMG79RF3UWNU0R52

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco Dorsey Wright Healthcare Momentum ETF

- **b. EDGAR series identifier (if any):** S000013104

- **c. LEI of Series:** 549300HW4X5F66JYEL71

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-04-30

- **b. Date as of which information is reported:** 2026-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $159525551.48

**Total Liabilities:** $38617034.02

**Net Assets:** $120908517.46

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000035320 | 3.16%                | -1.52%               | 3.05%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $238450.56               | $3633663.93                                |
| Month 2  | $1078340.29              | $-3073651.46                               |
| Month 3  | $5795254.15              | $-2754755.88                               |

### Schedule of Portfolio Investments

| Name                                  | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Viridian Therapeutics, Inc.           | Viridian Therapeutics, Inc.                                | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |     52099 | NS      | $702294.52    | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc.           | Ligand Pharmaceuticals Inc.                                | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      8520 | NS      | $1954914.00   | 1.62%             |  |  |  | No            |                  1 | On Loan: —       |
| Brookdale Senior Living Inc.          | Brookdale Senior Living Inc.                               | CUSIP: 112463104<br>LEI: LH7MQB13NWY7CJ9VC445 | Long             | EC               | CORP              | US        |    118923 | NS      | $1707734.28   | 1.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc.             | Elanco Animal Health Inc.                                  | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |     62951 | NS      | $1408213.87   | 1.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics, Inc.             | Axsome Therapeutics, Inc.                                  | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     15385 | NS      | $3196233.75   | 2.64%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Healthcare, Inc.                  | HCA Healthcare, Inc.                                       | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |      7728 | NS      | $3357429.60   | 2.78%             |  |  |  | No            |                  1 | On Loan: No      |
| BioAge Labs, Inc.                     | BioAge Labs, Inc.                                          | CUSIP: 09077V100<br>LEI: 529900NG0C40250Z7875 | Long             | EC               | CORP              | US        |     55347 | NS      | $932596.95    | 0.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Axogen, Inc.                          | Axogen, Inc.                                               | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     38310 | NS      | $1654992.00   | 1.37%             |  |  |  | No            |                  1 | On Loan: —       |
| SELLAS Life Sciences Group, Inc.      | SELLAS Life Sciences Group, Inc.                           | CUSIP: 81642T209<br>LEI: 549300VZIH50VYURLQ98 | Long             | EC               | CORP              | US        |    367216 | NS      | $1817719.20   | 1.50%             |  |  |  | No            |                  1 | On Loan: —       |
| Praxis Precision Medicines, Inc.      | Praxis Precision Medicines, Inc.                           | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19267 | NS      | $6142897.61   | 5.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora, Inc.                         | Cencora, Inc.                                              | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |      8829 | NS      | $2719420.29   | 2.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences, Inc.                 | Gilead Sciences, Inc.                                      | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     18363 | NS      | $2402614.92   | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC              | Jazz Pharmaceuticals PLC                                   | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     11426 | NS      | $2319706.52   | 1.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences, Inc.               | Arcus Biosciences, Inc.                                    | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     44685 | NS      | $1139467.50   | 0.94%             |  |  |  | No            |                  1 | On Loan: —       |
| Incyte Corp.                          | Incyte Corp.                                               | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     21763 | NS      | $2073361.01   | 1.71%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp.             | United Therapeutics Corp.                                  | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      7268 | NS      | $4152571.80   | 3.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis, Inc.                        | Exelixis, Inc.                                             | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |     36251 | NS      | $1611719.46   | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Erasca, Inc.                          | Erasca, Inc.                                               | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    194096 | NS      | $2067122.40   | 1.71%             |  |  |  | No            |                  1 | On Loan: —       |
| Syndax Pharmaceuticals, Inc.          | Syndax Pharmaceuticals, Inc.                               | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |     41013 | NS      | $878908.59    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd.                 | Roivant Sciences Ltd.                                      | CUSIP: G76279101<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |    197099 | NS      | $5623234.47   | 4.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Krystal Biotech, Inc.                 | Krystal Biotech, Inc.                                      | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      5073 | NS      | $1330444.98   | 1.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Zenas Biopharma, Inc.                 | Zenas Biopharma, Inc.                                      | CUSIP: 98937L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39681 | NS      | $766636.92    | 0.63%             |  |  |  | No            |                  1 | On Loan: —       |
| Capricor Therapeutics, Inc.           | Capricor Therapeutics, Inc.                                | CUSIP: 14070B309<br>LEI: 5493002ZI5PDLXV4DX14 | Long             | EC               | CORP              | US        |     81402 | NS      | $2733479.16   | 2.26%             |  |  |  | No            |                  1 | On Loan: —       |
| Ensign Group, Inc. (The)              | Ensign Group, Inc. (The)                                   | CUSIP: 29358P101<br>LEI: 5493003K4HEEA8Q0BC72 | Long             | EC               | CORP              | US        |     11223 | NS      | $2095221.87   | 1.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc.                         | Celcuity Inc.                                              | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |     25182 | NS      | $3055835.70   | 2.53%             |  |  |  | No            |                  1 | On Loan: —       |
| Perspective Therapeutics Inc.         | Perspective Therapeutics Inc.                              | CUSIP: 46489V302<br>LEI: 5493005LRKM6BCABC605 | Long             | EC               | CORP              | US        |    207471 | NS      | $809136.90    | 0.67%             |  |  |  | No            |                  1 | On Loan: —       |
| Moderna, Inc.                         | Moderna, Inc.                                              | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |     50080 | NS      | $2300675.20   | 1.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte, Inc.                         | Vaxcyte, Inc.                                              | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |     23663 | NS      | $1354470.12   | 1.12%             |  |  |  | No            |                  1 | On Loan: —       |
| MoonLake Immunotherapeutics           | MoonLake Immunotherapeutics                                | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |     58091 | NS      | $951530.58    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Private Prime Fund            | Invesco Private Prime Fund                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  27706338 | NS      | $27709108.63  | 22.92%            |  |  |  | No            |                  2 | On Loan: No      |
| Trevi Therapeutics, Inc.              | Trevi Therapeutics, Inc.                                   | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    114114 | NS      | $1570208.64   | 1.30%             |  |  |  | No            |                  1 | On Loan: —       |
| Kodiak Sciences Inc.                  | Kodiak Sciences Inc.                                       | CUSIP: 50015M109<br>LEI: 254900IXI5NI8C9OQE24 | Long             | EC               | CORP              | US        |     55223 | NS      | $2401096.04   | 1.99%             |  |  |  | No            |                  1 | On Loan: —       |
| Oruka Therapeutics, Inc.              | Oruka Therapeutics, Inc.                                   | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |     28323 | NS      | $1937576.43   | 1.60%             |  |  |  | No            |                  1 | On Loan: —       |
| Tyra Biosciences, Inc.                | Tyra Biosciences, Inc.                                     | CUSIP: 90240B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     53591 | NS      | $1862287.25   | 1.54%             |  |  |  | No            |                  1 | On Loan: —       |
| Annexon, Inc.                         | Annexon, Inc.                                              | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    188931 | NS      | $1109024.97   | 0.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Tango Therapeutics Inc.               | Tango Therapeutics Inc.                                    | CUSIP: 87583X109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    159490 | NS      | $3448173.80   | 2.85%             |  |  |  | No            |                  1 | On Loan: —       |
| Ionis Pharmaceuticals, Inc.           | Ionis Pharmaceuticals, Inc.                                | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |     38394 | NS      | $2870335.44   | 2.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Phibro Animal Health Corp.            | Phibro Animal Health Corp., Class A                        | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |     20545 | NS      | $1092583.10   | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Tenet Healthcare Corp.                | Tenet Healthcare Corp.                                     | CUSIP: 88033G407<br>LEI: 0W9AIBT6U6ADJ2I8HK17 | Long             | EC               | CORP              | US        |     20745 | NS      | $3674354.40   | 3.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Maze Therapeutics, Inc.               | Maze Therapeutics, Inc.                                    | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23066 | NS      | $613094.28    | 0.51%             |  |  |  | No            |                  1 | On Loan: —       |
| AnaptysBio, Inc.                      | AnaptysBio, Inc.                                           | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |     32708 | NS      | $2149896.84   | 1.78%             |  |  |  | No            |                  1 | On Loan: —       |
| Dianthus Therapeutics, Inc.           | Dianthus Therapeutics, Inc.                                | CUSIP: 252828108<br>LEI: 549300Z3N6ODPCOFC890 | Long             | EC               | CORP              | US        |     24726 | NS      | $2170942.80   | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc.                          | Viatris Inc.                                               | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    152008 | NS      | $2270999.52   | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp.                | Twist Bioscience Corp.                                     | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |     30064 | NS      | $1757240.80   | 1.45%             |  |  |  | No            |                  1 | On Loan: —       |
| Cytokinetics, Inc.                    | Cytokinetics, Inc.                                         | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |     22459 | NS      | $1436702.23   | 1.19%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio, Institutional Class | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |    322236 | NS      | $322235.69    | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Private Government Fund       | Invesco Private Government Fund                            | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  10675160 | NS      | $10675159.86  | 8.83%             |  |  |  | No            |                  2 | On Loan: No      |
| Edgewise Therapeutics, Inc.           | Edgewise Therapeutics, Inc.                                | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51209 | NS      | $1585430.64   | 1.31%             |  |  |  | No            |                  1 | On Loan: —       |
| Enliven Therapeutics, Inc.            | Enliven Therapeutics, Inc.                                 | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     31343 | NS      | $1292271.89   | 1.07%             |  |  |  | No            |                  1 | On Loan: —       |
| Protagonist Therapeutics, Inc.        | Protagonist Therapeutics, Inc.                             | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23165 | NS      | $2292640.05   | 1.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp.                        | Liquidia Corp.                                             | CUSIP: 53635D202<br>LEI: 549300O826O5VQJTG707 | Long             | EC               | CORP              | US        |     43673 | NS      | $1712418.33   | 1.42%             |  |  |  | No            |                  1 | On Loan: —       |
| Alumis Inc.                           | Alumis Inc.                                                | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    103872 | NS      | $2564599.68   | 2.12%             |  |  |  | No            |                  1 | On Loan: —       |
| Terns Pharmaceuticals, Inc.           | Terns Pharmaceuticals, Inc.                                | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |     65368 | NS      | $3459928.24   | 2.86%             |  |  |  | No            |                  1 | On Loan: No      |
| BrightSpring Health Services, Inc.    | BrightSpring Health Services, Inc.                         | CUSIP: 10950A106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     49825 | NS      | $2390105.25   | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Spyre Therapeutics, Inc.              | Spyre Therapeutics, Inc.                                   | CUSIP: 00773J202<br>LEI: 52990017AIJPRH3HQH40 | Long             | EC               | CORP              | US        |     24120 | NS      | $1795734.00   | 1.49%             |  |  |  | No            |                  1 | On Loan: —       |
| Nektar Therapeutics                   | Nektar Therapeutics                                        | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |     36570 | NS      | $3109912.80   | 2.57%             |  |  |  | No            |                  1 | On Loan: —       |
| CG Oncology, Inc.                     | CG Oncology, Inc.                                          | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     28115 | NS      | $1876395.10   | 1.55%             |  |  |  | No            |                  1 | On Loan: —       |
| Kymera Therapeutics, Inc.             | Kymera Therapeutics, Inc.                                  | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21835 | NS      | $1770163.45   | 1.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Stoke Therapeutics, Inc.              | Stoke Therapeutics, Inc.                                   | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |     33715 | NS      | $1103154.80   | 0.91%             |  |  |  | No            |                  1 | On Loan: —       |
| Relay Therapeutics, Inc.              | Relay Therapeutics, Inc.                                   | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    105574 | NS      | $1368239.04   | 1.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Dyne Therapeutics, Inc.               | Dyne Therapeutics, Inc.                                    | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     77358 | NS      | $1357632.90   | 1.12%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2026-05-30

**Name of Applicant:** Invesco Exchange-Traded Fund Trust

**Signature:** Adrien Deberghes

**Name of Signer:** Adrien Deberghes

**Title:** Vice President